JP2008056680A5 - - Google Patents

Download PDF

Info

Publication number
JP2008056680A5
JP2008056680A5 JP2007239523A JP2007239523A JP2008056680A5 JP 2008056680 A5 JP2008056680 A5 JP 2008056680A5 JP 2007239523 A JP2007239523 A JP 2007239523A JP 2007239523 A JP2007239523 A JP 2007239523A JP 2008056680 A5 JP2008056680 A5 JP 2008056680A5
Authority
JP
Japan
Prior art keywords
asthma
bronchitis
group
bronchiectasis
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007239523A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008056680A (ja
JP4819770B2 (ja
Filing date
Publication date
Priority claimed from GB0425054A external-priority patent/GB0425054D0/en
Application filed filed Critical
Publication of JP2008056680A publication Critical patent/JP2008056680A/ja
Publication of JP2008056680A5 publication Critical patent/JP2008056680A5/ja
Application granted granted Critical
Publication of JP4819770B2 publication Critical patent/JP4819770B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007239523A 2004-03-23 2007-09-14 アドレナリン受容体として有用なホルムアミド誘導体 Expired - Fee Related JP4819770B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04290767.5 2004-03-23
EP04290767 2004-03-23
GB0425054.4 2004-11-12
GB0425054A GB0425054D0 (en) 2004-03-23 2004-11-12 Formamide derivatives for the treatment of diseases

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007504493A Division JP4033892B2 (ja) 2004-03-23 2005-03-10 アドレナリン受容体として有用なホルムアミド誘導体

Publications (3)

Publication Number Publication Date
JP2008056680A JP2008056680A (ja) 2008-03-13
JP2008056680A5 true JP2008056680A5 (cg-RX-API-DMAC7.html) 2008-04-24
JP4819770B2 JP4819770B2 (ja) 2011-11-24

Family

ID=35432183

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007504493A Expired - Fee Related JP4033892B2 (ja) 2004-03-23 2005-03-10 アドレナリン受容体として有用なホルムアミド誘導体
JP2007239523A Expired - Fee Related JP4819770B2 (ja) 2004-03-23 2007-09-14 アドレナリン受容体として有用なホルムアミド誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007504493A Expired - Fee Related JP4033892B2 (ja) 2004-03-23 2005-03-10 アドレナリン受容体として有用なホルムアミド誘導体

Country Status (30)

Country Link
JP (2) JP4033892B2 (cg-RX-API-DMAC7.html)
KR (1) KR100806478B1 (cg-RX-API-DMAC7.html)
AR (1) AR050236A1 (cg-RX-API-DMAC7.html)
AT (1) ATE469121T1 (cg-RX-API-DMAC7.html)
CA (1) CA2560547C (cg-RX-API-DMAC7.html)
CY (1) CY1112549T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005021472D1 (cg-RX-API-DMAC7.html)
DK (1) DK1730103T3 (cg-RX-API-DMAC7.html)
DO (1) DOP2005000045A (cg-RX-API-DMAC7.html)
EA (1) EA010133B1 (cg-RX-API-DMAC7.html)
ES (1) ES2343808T3 (cg-RX-API-DMAC7.html)
GB (1) GB0425054D0 (cg-RX-API-DMAC7.html)
GE (1) GEP20084455B (cg-RX-API-DMAC7.html)
HN (1) HN2005000118A (cg-RX-API-DMAC7.html)
HR (1) HRP20100402T1 (cg-RX-API-DMAC7.html)
IL (1) IL178102A (cg-RX-API-DMAC7.html)
IS (1) IS8552A (cg-RX-API-DMAC7.html)
MA (1) MA28480B1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06011019A (cg-RX-API-DMAC7.html)
MY (1) MY144103A (cg-RX-API-DMAC7.html)
NL (1) NL1028597C2 (cg-RX-API-DMAC7.html)
NO (1) NO20064806L (cg-RX-API-DMAC7.html)
NZ (1) NZ549839A (cg-RX-API-DMAC7.html)
PE (1) PE20060264A1 (cg-RX-API-DMAC7.html)
PT (1) PT1730103E (cg-RX-API-DMAC7.html)
RS (1) RS51438B (cg-RX-API-DMAC7.html)
SI (1) SI1730103T1 (cg-RX-API-DMAC7.html)
SV (1) SV2005002056A (cg-RX-API-DMAC7.html)
TW (1) TWI335312B (cg-RX-API-DMAC7.html)
UY (1) UY28819A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2005492A6 (es) * 1987-12-23 1989-03-01 Lasa Lab Procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2((2- (4-metoxifenil)-1metiletil)amino)etil)fenil)foramida (i).
CH686869A5 (de) * 1991-04-05 1996-07-31 Sepracor Inc Beta (2) -bronchienerweiternde Arzneistoffe in Form ihrer Bronchienerweiternden Enantiomeren zur Verwendung fuer die Herstellung eines Mittels zur verbesserten Therapie.
UA73965C2 (en) * 1999-12-08 2005-10-17 Theravance Inc b2 ADRENERGIC RECEPTOR ANTAGONISTS
OA11558A (en) * 1999-12-08 2004-06-03 Advanced Medicine Inc Beta 2-adrenergic receptor agonists.
US6653323B2 (en) * 2001-11-13 2003-11-25 Theravance, Inc. Aryl aniline β2 adrenergic receptor agonists
TWI249515B (en) * 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
EP1507754A1 (en) * 2002-05-28 2005-02-23 Theravance, Inc. Alkoxy aryl beta-2 adrenergic receptor agonists
JP4767842B2 (ja) * 2003-04-01 2011-09-07 セラヴァンス, インコーポレーテッド β2アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物
US7268147B2 (en) * 2003-05-15 2007-09-11 Pfizer Inc Compounds useful for the treatment of diseases
CA2553789C (en) * 2004-01-22 2011-07-19 Pfizer Inc. Sulfonamide derivatives for the treatment of diseases
WO2005092861A1 (en) * 2004-03-11 2005-10-06 Pfizer Limited Quinolinone derivatives pharmaceutical compositions containing them and their use
EA200601510A1 (ru) * 2004-03-17 2007-04-27 Пфайзер Инк. Производные фенилэтаноламина в качестве бета-2-агонистов
AU2005225638A1 (en) * 2004-03-23 2005-10-06 Pfizer Inc. Compounds for the treatment of diseases
WO2005092841A1 (en) * 2004-03-23 2005-10-06 Pfizer Limited Compounds having beta-agonist activity

Similar Documents

Publication Publication Date Title
JP2009530364A5 (cg-RX-API-DMAC7.html)
JP2007529499A5 (cg-RX-API-DMAC7.html)
RU2009134512A (ru) Гидрохлоридная соль 5-[3-(3-гидроксифенокси)азетедин-1-ил]-5-метил-2,2-дифенилгексанамида
JP5567252B2 (ja) グリコピロレートおよびベータ2アドレナリン受容体アゴニストの組合せ剤
EP2117542B1 (en) Combinations of beta- 2 -adrenoceptor agonistic benzothiazolone
JP2023072065A (ja) 3,5-ジアミノ-6-クロロ-n-(n-(4-(4-(2-(ヘキシル(2,3,4,5,6-ペンタヒドロキシヘキシル)アミノ)エトキシ)フェニル)ブチル)カルバミミドイル)ピラジン-2-カルボキサミド
KR101805958B1 (ko) 포스포디에스테라제 억제제를 포함하는 건조 분말 제제
ES2647486T3 (es) Pirazolo[1,5-a]pirimidinas como agentes antivirales
KR102258469B1 (ko) 불충분한 점막 수화에 의해 유발되는 질환의 치료에 유용한 클로로-피라진 카르복스아미드 유도체
ES2330047T3 (es) Combinacion de r,r-glicopirrolato, rolipram y budesonida para el tratmiento de enfermedades inflamatorias.
JP2006517939A5 (cg-RX-API-DMAC7.html)
US20140336159A1 (en) Methods for treating and diagnosing respiratory tract infections
CN103687488B (zh) 化学和代谢稳定的具有钠通道阻滞剂活性的二肽
ES2293530T3 (es) Derivados de sulfonamidas para el tratamiento de enfermedades.
JP2007522141A (ja) 呼吸器疾患の処置のためのベンゾチアゾール−2−オンベータ2アドレナリン受容体アゴニストとコルチコステロイドの組合せ剤
RU2008129620A (ru) Пиразиноилгуанидиновые соединения, применяемые в лечении воспалительных или аллергических заболеваний
HRP20191756T1 (hr) Spirociklički inhibitori katepsina c
DE60125026D1 (de) Fluorisochinolinderivate, verfahren zu ihrer herstellung und ihre anwendung
JP2007501269A5 (cg-RX-API-DMAC7.html)
RU2011110908A (ru) Тиенопиримидины для фармацевтических композиций
JP2024540525A5 (cg-RX-API-DMAC7.html)
RU2015121046A (ru) Соединения, обладающие активностью антагонистов мускариновых рецепторов и агонистов бета-2-адренергических рецепторов
CA2623332A1 (en) Carboxamide derivatives as muscarinic receptor antagonists
ATE541570T1 (de) Kombination von anticholinergika und hemmern von phosphodiesterase typ 4 zur behandlung von atemwegserkrankungen
CN109790170B (zh) Gaba(a)受体调节剂和控制哮喘中气道高反应性和炎症的方法